The government has proposed the Biopharma SHAKTI (Strategy for Healthcare Advancement through Knowledge, Technology and Innovation) initiative in the 2026-27 Union Budget to position India as a global biopharmaceutical manufacturing hub. The initiative, with a total budget of 10 thousand crore...
biologics
biopharmaceutical manufacturing
biosimilars
economic survey
generic medicines
government policy
healthcare
india
india economy
manufacturing
pharmaceutical exports
pharmaceutical industry
strategic initiative
therapeutic categories
union budget
New Delhi, March 3 Prime Minister Narendra Modi on Tuesday urged industry leaders to increase investments, adopt emerging technologies, and prioritize research to leverage the vast opportunities offered by free trade agreements with various nations.Addressing the second webinar on the Budget...
Prime Minister Narendra Modi stated that India remains a beacon of hope for the world due to its strong economy. He said that as India emerges as a beacon of hope, rapid economic development has become essential for achieving the vision of "Viksit Bharat" (Developed India).Speaking in a...
biologics
biopharma
connectivity
economic development
global economy
india economy
investment
manufacturing
msme sector
next-generation therapies
research and development
sustainable development
trade agreements
transport infrastructure
viksit bharat
THIRUVANANTHAPURAM, March 1: Union Minister Dr. Jitendra Singh inaugurated the state-of-the-art "Central Facility for Recombinant Cells and Sensors" at the BRIC-Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB), aimed at advancing drug discovery and medical and agricultural genomics.The...
agricultural genomics
bioe3 policy
biologics
biotechnology
bric-rajiv gandhi centre for biotechnology
car-t therapy
cell-based therapies
department of biotechnology
drug discovery
genomics
healthcare
india
medical research
non-communicable diseases
recombinant cells
New Delhi, February 19 Zydus Lifesciences announced on Thursday that it has launched its first biosimilar, developed indigenously, for the treatment of visual impairment.Anyra, the country's first biosimilar of Aflibercept 2 mg, is indicated for the treatment of visual impairment caused by...
aflibercept
anyra
bayer
biologics
biosimilar
diabetes
drug development
gujarat
healthcare
india
ophthalmic care
pharmaceuticals
regeneron pharmaceuticals
visual impairment
zydus lifesciences
Telangana Chief Minister A. Revanth Reddy will inaugurate the 23rd edition of BioAsia 2026 international summit today. The two-day global conference will be held at the Hyderabad International Convention Centre (HICC). This year's summit is themed "TechBio Unleashed – AI, Automation, and the...